Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin
Alexander M. Sherwood, Adam L. Halberstadt, Adam K. Klein, John D. Mccorvy, Kristi W. Kaylo, Robert B. Kargbo, Poncho Meisenheimer
Journal of Natural Products February 20, 2020 DOI: 10.1021/acs.jnatprod.9b01061 via OpenAlex
Summary
AI-generated from the abstractA new synthetic method allows access to tryptamine natural products found in psilocybin-producing mushrooms. Laboratory and animal experiments tested whether these compounds are psychoactive. In mice, the natural product baeocystin did not produce a head twitch response, a behavioral marker of psychedelic activity, even though its predicted breakdown product, norpsilocin, strongly activates the 5-HT2A receptor, which is associated with psychedelic effects. This suggests that baeocystin itself may not be psychedelic, despite its metabolite's activity.
Study at a glance
| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Mice |
| Interventions | baeocystin norpsilocin |
| Topics | Psilocybin |
| Keywords | Tryptamines Hallucinogen Metabolite Pharmacology |
| Citations | 79 |
| Key finding | Baeocystin alone did not show psychedelic activity in the mouse head twitch response assay, whereas its metabolite norpsilocin is a potent 5-HT2A receptor agonist. |
Abstract
A general synthetic method was developed to access known tryptamine natural products present in psilocybin-producing mushrooms. In vitro and in vivo experiments were then conducted to inform speculations on the psychoactive properties, or lack thereof, of the natural products. In animal models, psychedelic activity by baeocystin alone was not evident using the mouse head twitch response assay, despite its putative dephosphorylated metabolite, norpsilocin, possessing potent agonist activity at the 5-HT2A receptor.